- · 《知识文库》栏目设置[06/30]
- · 《知识文库》收稿方向[06/30]
- · 《知识文库》投稿方式[06/30]
- · 《知识文库》征稿要求[06/30]
- · 《知识文库》刊物宗旨[06/30]
文库筛选技术的发展及在肿瘤研究中的应用(5)
作者:网站采编关键词:
摘要:[24]Hart T,Chandrashekhar M,Aregger M,et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities[J].Cell,2015,163(6):1515-26. [25]Korkmaz G,Lopes R,Ugalde AP,e
[24]Hart T,Chandrashekhar M,Aregger M,et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities[J].Cell,2015,163(6):1515-26.
[25]Korkmaz G,Lopes R,Ugalde AP,et al. Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9[J].Nat Biotechnol,2016,34(2):192-8.
[26]Stolte B,Iniguez AB,Dharia NV,et CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma[J].J Exp Med,2018,215(8):2137-55.
[27]Chen L,Alexe G,Dharia NV,et al. CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2[J]. J Clin Invest,2018,128(1):446-62.
[28]Song C,Li Y,Mou H,et CRISPR screen identifies regulators of mitogen-activated protein kinase as suppressors of liver tumors in mice[J].Gastroenterology,2017,152(5):1161-73.
[29]Zhu S,Li W,Liu J,et deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library[J].Nat Biotechnol,2016,34(12):1279-86.
[30]高庆祝,汪 凯,梁 利,等.基于CRISPR/Cas9系统构建ARID2基因敲除模型并探索其对肝癌细胞增殖和迁移能力的影响[J].重庆医科大学学报,2017(7):850-5.
[31]Song C,Li Y,Mou H,et CRISPR screen identifies regulators of mitogen-activated protein kinase as suppressors of liver tumors in mice[J].Gastroenterology,2017,152(5):1161-73.
[32]Shen JP,Zhao D,Sasik R,et al. Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions[J]. Nat Methods,2017,14(6):573-6.
[33]Chow RD,Guzman CD,Wang G,et direct in vivo CRISPR screen identifies functional suppressors in glioblastoma[J].Nat Neurosci,2017,20(10):1329-41.
[34]Oser MG,Fonseca R,Chakraborty AA,et al. Cells lacking theRB1 tumor suppressor gene are hyperdependent on Aurora B kinase for survival[J].Cancer Discov,2019,9(2):230-47.
[35]Kong X,Kuilman T,Shahrabi A,et al. Cancer drug addiction is relayed by an ERK2-dependent phenotype Switch[J].Nature,2017,550(7675):270-4.
[36]Tahir SK,Smith ML,Hessler P,et al. Potential mechanisms of resistance to venetoclax and strategies to circumvent it[J]. BMC Cancer,2017,17(1):399.
[37]Chin HS,Li MX,Tan IL,et al. VDAC2 enables BAX to mediate apoptosis and limit tumor development[J]. Nat Commun,2018,9(1):4976.
[38]Yamauchi T,Masuda T,Canver MC,et al. Genome-wide CRISPRCas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS[J].Cancer Cell,2018,33(3):386-400.
[39]Manguso RT,Pope HW,Zimmer MD,et al.In vivoCRISPR screening identifies Ptpn2 as a cancer immunotherapy target[J].Nature,2017,547(7664):413-8.
[40]Burr ML,Sparbier CE,Chan Y,et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity[J].Nature,2017,549(7670):101-5.
[41]Patel SJ,Sanjana NE,Kishton RJ,et al. Identification of essential genes for cancer immunotherapy[J].Nature,2017,548(7669):537-42.
[42]Pan D,Kobayashi A,Jiang P,et al. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing[J].Science,2018,359(6377):770-5.
[43]Cyranoski D.First trial of CRISPR in People[J].Nature,2016,535(7613):476.
文章来源:《知识文库》 网址: http://www.zswkbjb.cn/qikandaodu/2021/0316/779.html
上一篇:编辑手记求同存异和精益求精
下一篇:高职护理学生对新冠肺炎的认知态度和行为调查